HUM vs OGN · P/E 39, rev $117.76B vs P/E 3.4, rev $6.40B
Humana Inc (HUM) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the HUM and OGN stock pages for the full models.
Not investment advice.